SOLICITATION NOTICE
A -- A Mouse Testing Facility for Screening of Small Molecule Therapeutics for Spinal Muscular Atrophy
- Notice Date
- 7/29/2004
- Notice Type
- Solicitation Notice
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, Science Applications International Corporation (SAIC)(NINDS Prime Contractor), 5340 Spectrum Drive, Suite N, Frederick, MD, 21703-7357
- ZIP Code
- 21703-7357
- Solicitation Number
- JL19704-1
- Response Due
- 9/8/2004
- Archive Date
- 9/23/2004
- Point of Contact
- Adam Book, Peer Review Scientist, Phone 301-228-3114, Fax 301-698-6188, - Adam Book, Peer Review Scientist, Phone 301-228-3114, Fax 301-698-6188,
- E-Mail Address
-
adam.a.book@saic.com, adam.a.book@saic.com
- Description
- The SMA Project (http://www.SMAProject.org) is currently requesting proposals for a facility or facilities to provide (1) efficacy testing of compounds in mouse models of spinal muscular atrophy (SMA) and/or (2) the prerequisite in vivo pharmacologic, pharmacokinetic, and toxicologic studies that are necessary for the design and commencement of efficacy testing in mouse models of SMA. (Please note that prerequisite in vivo pharmacologic and toxicologic studies are NOT pivotal preclinical studies performed under Good Laboratory Practices [GLP].) Offerors may submit proposals to support either or both mouse testing facility services. Proposals are due on September 8, 2004. Proposals and accompanying documents can be accessed through the ?Open Solicitations? page of the SMA Project website (http://www.smaproject.org/Solicitations/opensolicitations.htm). The National Institute for Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov/) launched The SMA Project: A Collaborative Program to Accelerate Therapeutics Development for Spinal Muscular Atrophy in September 2003. This program funds milestone-driven research aimed at identifying and rapidly developing a treatment for SMA, a paralyzing neurodegenerative disease of childhood. Science Applications International Corporation (SAIC) is supporting the NINDS in the management of this program. Any responsible Offeror may submit a proposal to be considered by SAIC.
- Place of Performance
- Address: Offeror's facilities
- Record
- SN00632794-W 20040731/040729211809 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |